Linda Scully

The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

Karen Cauch‐Dudek, Valery Walker, Robert J. Bailey et al. · Hepatology · 1994 · 444 citations

Medicine, Internal Medicine, Pharmacotherapy +17

Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, with survival analysis

Michael Wilschanski, Peter Chait, Judy Wade et al. · Hepatology · 1995 · 220 citations

Medicine, Pathology, Pediatrics +15

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant α-interferon

J.A. McDonald, L. Caruso, Peter Karayiannis et al. · Hepatology · 1987 · 140 citations

Life Sciences, Immunology, Infectious Diseases +12

Anti-ribosomal P Antibodies in Systemic Lupus Erythematosus: A Case-Control Study Correlating Hepatic and Renal Disease

Mark Hulsey, Rose Goldstein, Linda Scully et al. · Clinical Immunology and Immunopathology · 1995 · 114 citations

Life Sciences, Immunology, Pathology +12

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

M.R. Kilmurry, E. Jenny Heathcote, Karen Cauch‐Dudek et al. · Hepatology · 1996 · 93 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14